Clinical trial
A Prospective, Multi-center, 3-month, Observational Study to Evaluate the Effectiveness and Safety of Lemborexant in Chinese Patients With Insomnia in Real World Setting.
NCT06225947 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, 3-month, Observational Study to Evaluate the Effectiveness and Safety of Lemborexant in Chinese Patients With Insomnia in Real World Setting.
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 22, 2024
- Completion date
- June 30, 2025
- Enrollment
- 200 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia